Alembic Pharma's consolidated profit rose 21% to Rs 185 crore in Q2 FY26, led by strong performance in US generics, APIs, and ...
Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...
Texas-based steel manufacturer continues to leverage ISNetworld (R) to help improve workforce-readiness ISN, the global leader in contractor and supplier information management services, celebrated ...
SGNL's pioneering Continuous Identity approach and technology delivers real-time access decisions for global Fortune 100 enterprises ...
Features: AI infrastructure is accelerating India’s digital ambitions, enabling smarter decisions and faster innovation ...
Features: AI infrastructure is accelerating India’s digital ambitions, enabling smarter decisions and faster innovation ...
Interdisciplinary work across multiple teams and initiatives can pose a challenge when it comes to satisfying customers as well as business objectives, finds Jérôme Goulard of Orange Business ...
Better.com, the leading AI-powered mortgage lender, today announced that Keith Soura, Vice President of Engineering at Better.com, has been named a 2025 HousingWire Tech Trendsetter. The award ...
The global AI-Powered Pathology Market is projected to grow significantly in the coming years. It was valued at USD 184 Million in 2023 and is forecast to reach USD 382 Million by 2030, representing a ...
The Register on MSN
Deploying to Amazon's cloud is a pain in the AWS younger devs won't tolerate
They have no need to prove their bonafides Recently, I was spinning up yet another terribly coded thing for fun because I ...
Capital Market on MSN
Alembic Pharma gains after Q2 PAT climbs 20% YoY to Rs 185 cr
Revenue from operations grew 15.90% year on year (YoY) to Rs 1,910.15 crore in the quarter ended 30 September 2025.
On October 15, 2021, JARXE Exchange officially obtained the Money Services Business (MSB) license issued by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results